BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28033083)

  • 1. The Hemodynamic Effects and Safety of Repetitive Levosimendan Infusions on Children With Dilated Cardiomyopathy.
    Suominen P; Mattila N; Nyblom O; Rautiainen P; Turanlahti M; Rahkonen O
    World J Pediatr Congenit Heart Surg; 2017 Jan; 8(1):25-31. PubMed ID: 28033083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
    Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W
    Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery.
    Turanlahti M; Boldt T; Palkama T; Antila S; Lehtonen L; Pesonen E
    Pediatr Crit Care Med; 2004 Sep; 5(5):457-62. PubMed ID: 15329162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
    Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO
    Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early experience with Levosimendan in children with ventricular dysfunction.
    Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
    Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of acute decompensated heart failure with levosimendan].
    Müller K; Peters A; Zeus T; Hennersdorf M; Strauer BE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():119-22. PubMed ID: 16802535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
    Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
    J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension.
    Lobo Martínez P; Oulego Erroz I; Gautreux Minaya S; Rodríguez Fernández LM
    Pediatr Cardiol; 2011 Oct; 32(7):1012-6. PubMed ID: 21744292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic preoperative levosimendan administration in heart failure patients undergoing elective non-cardiac surgery: a preliminary report.
    Katsaragakis S; Kapralou A; Drimousis P; Markogiannakis H; Larentzakis A; Kofinas G; Misthos P; Filis K; Theodorou D
    Hellenic J Cardiol; 2009; 50(3):185-92. PubMed ID: 19465359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
    Pölzl G; Altenberger J; Baholli L; Beltrán P; Borbély A; Comin-Colet J; Delgado JF; Fedele F; Fontana A; Fruhwald F; Giamouzis G; Giannakoulas G; Garcia-González MJ; Gustafsson F; Kaikkonen K; Kivikko M; Kubica J; von Lewinski D; Löfman I; Malfatto G; Manito N; Martínez-Sellés M; Masip J; Merkely B; Morandi F; Mølgaard H; Oliva F; Pantev E; Papp Z; Perna GP; Pfister R; Piazza V; Bover R; Rangel-Sousa D; Recio-Mayoral A; Reinecke A; Rieth A; Sarapohja T; Schmidt G; Seidel M; Störk S; Vrtovec B; Wikström G; Yerly P; Pollesello P
    Int J Cardiol; 2017 Sep; 243():389-395. PubMed ID: 28571618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
    Palmerini E; Söderberg S; Mondillo S; Favilli R; Lunghetti S
    Acute Card Care; 2015 Mar; 17(1):14-9. PubMed ID: 25806830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension].
    Martyniuk TV; Arkhipova OA; Kobal' EA; Danilov NM; Chazova IE
    Ter Arkh; 2012; 84(9):83-8. PubMed ID: 23091860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study.
    Bocchi EA; Vilas-Boas F; Moreira Mda C; Barretto AC; Lage S; Albuquerque D; Baima J; Rassi S; Ribeiro JP; ;
    Arq Bras Cardiol; 2008 Mar; 90(3):182-90. PubMed ID: 18392398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy.
    Yaman M; Arslan U; Kaya A; Akyol A; Ozturk F; Okudan YE; Bayramoglu A; Bektas O
    Cardiol J; 2016; 23(6):610-615. PubMed ID: 27910084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan for low cardiac output: a pediatric experience.
    Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
    J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan. A promising future drug for refractory cardiac failure in children?
    Kushwah S; Kumar A; Sahana KS
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S57-60. PubMed ID: 27056655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.